HMGB2 and pancreatic adenocarcinoma: HMGB2 up-expression suggested both worse OS and RFS of ACC, KIRP, LGG, and LIHC; worse OS of MESO and PAAD; worse RFS of LUAD and PRAD; and better OS of SKCM.